USD 0.32
(13.78%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 958.81 Million EGP | 922.73% |
2022 | 93.75 Million EGP | 22.8% |
2021 | 76.34 Million EGP | -83.62% |
2020 | 466.14 Million EGP | 30.33% |
2019 | 357.66 Million EGP | 114.14% |
2018 | 167.02 Million EGP | 20.25% |
2017 | 138.9 Million EGP | 16.1% |
2016 | 119.63 Million EGP | 98.32% |
2015 | 60.32 Million EGP | 10262.58% |
2014 | 582.16 Thousand EGP | -15.14% |
2013 | 686.05 Thousand EGP | -54.96% |
2012 | 1.52 Million EGP | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 1.01 Billion EGP | 0.0% |
2024 Q1 | 1.02 Billion EGP | -20.0% |
2023 Q4 | 958.81 Million EGP | 1.93% |
2023 Q1 | 79.56 Million EGP | -15.14% |
2023 FY | 958.81 Million EGP | 922.73% |
2023 Q2 | 79.56 Million EGP | 0.0% |
2023 Q3 | 940.63 Million EGP | 1082.3% |
2022 Q2 | 76.34 Million EGP | 0.0% |
2022 Q4 | 93.75 Million EGP | 42.34% |
2022 Q3 | 65.86 Million EGP | -13.73% |
2022 FY | 93.75 Million EGP | 22.8% |
2022 Q1 | 76.34 Million EGP | 0.0% |
2021 Q4 | 76.34 Million EGP | 12.95% |
2021 Q3 | 67.59 Million EGP | 18.59% |
2021 FY | 76.34 Million EGP | -83.62% |
2021 Q2 | 56.99 Million EGP | 0.0% |
2020 Q1 | - EGP | -100.0% |
2020 Q4 | 466.14 Million EGP | 0.0% |
2020 Q2 | 399.83 Million EGP | 0.0% |
2020 FY | 466.14 Million EGP | 30.33% |
2019 Q2 | 348.87 Million EGP | 0.0% |
2019 FY | 357.66 Million EGP | 114.14% |
2019 Q4 | 357.66 Million EGP | 0.0% |
2019 Q1 | - EGP | -100.0% |
2018 Q3 | - EGP | -100.0% |
2018 Q4 | 167.02 Million EGP | 0.0% |
2018 FY | 167.02 Million EGP | 20.25% |
2018 Q1 | 134.42 Million EGP | -3.22% |
2018 Q2 | 50.51 Million EGP | -62.42% |
2017 Q4 | 138.9 Million EGP | 0.0% |
2017 Q1 | 155.45 Million EGP | 29.94% |
2017 Q2 | 44.25 Million EGP | -71.53% |
2017 FY | 138.9 Million EGP | 16.1% |
2016 Q1 | 57.34 Million EGP | -4.95% |
2016 FY | 119.63 Million EGP | 98.32% |
2016 Q2 | 57.34 Million EGP | 0.0% |
2016 Q4 | 119.63 Million EGP | 0.0% |
2016 Q3 | - EGP | -100.0% |
2015 Q1 | 63.11 Million EGP | 10741.71% |
2015 FY | 60.32 Million EGP | 10262.58% |
2015 Q4 | 60.32 Million EGP | 0.0% |
2015 Q2 | 63.11 Million EGP | 0.0% |
2014 Q4 | 582.16 Thousand EGP | 0.0% |
2014 Q1 | - EGP | -100.0% |
2014 FY | 582.16 Thousand EGP | -15.14% |
2013 Q4 | 686.05 Thousand EGP | 0.0% |
2013 FY | 686.05 Thousand EGP | -54.96% |
2012 FY | 1.52 Million EGP | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Bio Medica Corporation | 6000.00 USD | -15980150.0% |
Arrayit Corporation | - USD | -Infinity% |
Atlantic International Corp. | 1.29 Million USD | -73796.312% |
Biocept, Inc. | 10.37 Million USD | -9141.59% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 51.3 Million USD | -1768.744% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | -1466.043% |
HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -175402.998% |
iMD Companies, Inc. | 1.1 Million USD | -86775.468% |
IDenta Corp. | 428.17 Thousand USD | -223830.113% |
Interpace Biosciences, Inc. | 4.24 Million USD | -22497.572% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | - USD | -Infinity% |
Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 278 Thousand USD | -344797.482% |
NovelStem International Corp. | 3.32 Million USD | -28740.02% |
Optigenex Inc. | 4.42 Million USD | -21558.019% |
PharmChem, Inc. | - USD | -Infinity% |
Proteome Sciences plc | 1.63 Million USD | -58686.941% |
Response Genetics, Inc | 4.91 Million USD | -19396.035% |
Rennova Health, Inc. | 359.19 Thousand USD | -266835.881% |
RushNet, Inc. | 4.25 Million USD | -22447.678% |
ScreenPro Security Inc. | 249.05 Thousand USD | -384888.958% |
Stella Diagnostics Inc. | 798.44 Thousand USD | -119985.892% |
StageZero Life Sciences Ltd. | 576.38 Thousand USD | -166250.615% |
Todos Medical Ltd. | 33 Million USD | -2805.412% |